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Lifespan: A Systematic and Critical Review
Amitai Abramovitch, PhD, Reuven Dar, PhD, Andrew Mittelman, BA, and Sabine Wilhelm, PhD
Abstract: The concept of comorbidity between attention deficit/hyperactivity disorder (ADHD) and obsessive-compulsive
disorder (OCD) has been discussed for two decades. No review, however, has examined this question in light of the stark
contrast in disorder-specific phenomenology and neurobiology. We review reported prevalence rates and the methodo-
logical, phenomenological, and theoretical issues concerning concomitant ADHD-OCD. Reported co-occurrence rates
are highly inconsistent in the literature. Studies aimed at examining the potential for comorbidity have suffered from var-
ious methodological problems, including the existence of very few community samples, highly variable exclusionary
criteria, and possible clinical misinterpretation of symptoms. Despite numerous studies suggesting an ADHD-OCD co-
morbidity, thus far etiological (i.e., genetic) backing has been provided only for a pediatric comorbidity. Additionally, in-
flated rates of ADHD-OCD co-occurrence may be mediated by the presence of tic disorders, and evidence of impaired
neuronal maturational processes in pediatric OCDmay lead to possibly transient phenotypical expressions that resemble
ADHD symptomatology. Thus, clinicians are encouraged to consider the possibility that ADHD-like symptoms resulting
from OCD-specific symptomatology may be misdiagnosed as ADHD. This suggestion may account for the lower co-
occurrence rates reported in adolescents and adults and for the lack of a theoretical account for comorbidity in these
age groups. Existing literature is summarized and critically reviewed, and recommendations aremade for future research.
Keywords: attention-deficit/hyperactivity disorder; comorbidity; diagnosis; obsessive-compulsive disorder; prevalence;
tic disorders
INTRODUCTION
Attention deficit/hyperactivity disorder (ADHD) and obsessive-
compulsive disorder (OCD) are commondevelopmental neuro-
psychiatric disorders associated with significant distress and
dysfunction. ADHD is characterized by inattention and by hy-
peractivity and impulsiveness present since childhood, whereas
OCD is characterized by intrusive obsessions and by compul-
sions that are typically performed in response to those obses-
sions. In the 1990s, studies examining the prevalence and
clinical manifestation of juvenile OCD began to report
elevated rates of co-occurring ADHD (i.e., the simultaneous
presentation of two diagnoses).1–5 Within a few years, numer-
ous studies reported ADHD-OCD comorbidity in pediatric
OCD samples.6–43 Fewer studies examined ADHD-OCD
comorbidity in adults.24,29,35,37,38,44–52
As we elaborate below, the research on ADHD-OCD co-
morbidity faces empirical and conceptual difficulties that are
likely interrelated. Empirically, reports of co-occurrence rates
are highly inconsistent, ranging from 0% to 60%,53 with
much lower co-occurrence rates reported in adults relative
to youth samples. Conceptually, the notion of genuine comor-
bidity between the two disorders (i.e., simultaneous presenta-
tion of the two disorders; as opposed to false comorbidity,
where symptoms of one disorder mimic those of the other)
is not easily reconciled with the fundamental neurobiological,
phenomenological, and behavioral differences betweenADHD
andOCD. For example, relative to controls, OCD patients ex-
hibit frontostriatal hyperactivation, whereas ADHD patients
exhibit frontostriatal hypoactivation. In addition, several po-
tential confounding factors (e.g., the mediating effect of tic dis-
orders, the presence of ADHD-like symptoms in OCD) may
contribute to the variability of reported co-occurrence rates
of the two disorders.53 In light of these difficulties, there is a
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need for a systematic and critical review of the studies reporting
co-occurrence between ADHD and OCD. In this article we aim
to (1) conduct a systematic review of reported ADHD-OCD
co-occurrence rates, (2) outline methodological caveats that
may have contributed to the variability seen across studies,
(3) evaluate the theoretical and etiological accounts for
ADHD-OCD comorbidity in light of fundamental neurobio-
logicalandclinicaldifferencesbetweenthe twodisorders, (4)ex-
amine potential confounding factors that may inflate reported
co-occurrence rates, and (5) offer directions for future research.
We begin our review by describing the differences be-
tween OCD and ADHD in terms of phenomenology, neuro-
biology, neuropsychology, and pharmacotherapy. We suggest
that these extensive differences pose a challenge for the concept
of genuine comorbidity between the two disorders, especially
in adults. We continue with a systematic review of reported
co-occurrence rates of ADHD and OCD. We then address
several methodological issues that may contribute to the var-
iability in reported co-occurrence rates, followed by examina-
tion of the available etiological accounts for ADHD-OCD
co-occurrence (which are presently limited to pediatric popu-
lations). Thereafter, we outline potential confounding factors
that may contribute to inflation of co-occurrence rates. Spe-
cifically, we suggest that the presence of tic disorders as well
as OCD-related executive function impairments may result
in ADHD symptoms in OCD that may further contribute to
inflatedreportedratesofconcomitance. Inaddition,wepropose
a neurodevelopmental perspective according towhich deficient
neuromaturational processes in pediatricOCDmay transiently
produce ADHD symptoms in children withOCD. Finally, we
outline implications and future directions for research.
Phenomenology of OCD and ADHD
ADHD is considered a congenital disorder with a strong her-
itable component.54OCD is also thought to have a hereditary
component.55,56 Estimated heritability in OCD (40%) is much
less prominent than in ADHD, however, in which 70%–80%
ofthephenotypicvariancecanbeexplainedbygenetic factors.57
In addition, whereas ADHDpresents in childhood, only 25%–
50%of adults withOCD experience onset before age 18.49
ADHD is an externalizing disorder characterized pre-
dominantly by inattention, behavioral impulsivity, and hyper-
activity; it is further associated with risk-taking behavior,
drug abuse, and novelty seeking.54,58,59 By contrast, OCD is
an internalizing disorder characterized predominantly by ob-
sessions and compulsions, and is associated with harm/risk
avoidance and restrained behavior.58,60–62 In contrast to the
prominent impulsiveness phenotype associated with ADHD,
OCD is associated with generally inhibited temperament typ-
ified by behavioral restraint, withdrawal, and avoidance of
novel stimuli.63,64 Moreover, studies indicate that individ-
uals diagnosed with OCD are no more behaviorally impul-
sive than nonpsychiatric control participants, with several
studies reporting lower levels of behavioral impulsivity in
OCD than in nonpsychiatric controls.60,65–68
When addressing the concept of comorbidity between
ADHD and OCD, it is useful to consider the notion of an
impulsive-compulsive continuum, as suggested by Hollander.69
According to this hypothetical scheme, the compulsive end of
this continuum—which is associated with OCD—is charac-
terized by harm avoidant and risk-aversive behaviors. Con-
versely, the impulsive end of the continuum is characterized
by behavioral impulsivity (i.e., behaviors lacking forethought)
and risk taking.69 According to Hollander, the concept of po-
larity between the two constructs is further supported by neu-
robiological and neurochemical differences. For example, on
the neurotransmitter level, impulsivity is mediated by dopa-
mine, whereas compulsivity is mediated by serotonin.69 In sum,
ADHD and OCD appear to be remarkably different in terms
of their phenomenology.53,70
Given that the symptoms of behavioral impulsivity differ
so dramatically between the two disorders, it may be reason-
able to assume that among OCD patients, there would be a
higher probability of identifying primary inattentive type of
ADHD (ADHD-I), rather than the predominantly hyperac-
tive subtype (ADHD-H) or the combined type (ADHD-C).
Estimations of the prevalence of ADHD subtypes vary as a
function of the assessment methods. A recent meta-analysis
reported, however, that best-estimation diagnosis yielded 57%
prevalence rates for ADHD-C, 30% for ADHD-I, and 13%
for ADHD-H.71 A limited number of studies reported the
breakdown of ADHD subtypes in individuals with ADHD-
OCD comorbidity. Some studies report percentages similar
to those in Willcutt’s meta-analysis. For example, Geller
and colleagues14 reported 69% of ADHD-C and 24% of
ADHD-I in a sample of youth with comorbid OCD and
ADHD.14 Other reports, however, indicated a subtype break-
down favoring ADHD-I. For example, Anholt and colleagues
(2010)35 found 48% ADHD-I and 36% ADHD-C in a
sample of adults with comorbid ADHD-OCD. In sum, the
data are currently too sparse to permit a persuasive infer-
ence regarding the speculative hypothesis of a higher prob-
ability of identifying ADHD-I in patients with comorbid
ADHD-OCD.
Neurobiology of ADHD and OCD
As one might expect from the phenomenological dissimilar-
ity, review of the ADHD and OCD neurobiological litera-
ture suggests that each disorder is associated with a distinct
pattern of brain pathophysiology. A large body of research
reveals an abnormal pattern of brain activity along the
frontostriatal system and among selected regions of interest
(see below) throughout this network in both ADHD72–74
and OCD.75–78 The frontostriatal functional abnormalities
contrast sharply, however, between the two disorders. OCD
is associatedwith abnormally increased activity (hypermetab-
olism) in frontal and striatal regions such as the orbitofrontal
cortex, the basal ganglia, and thalamus.75,77,79,80 Further-
more, OCD patients exhibit hyperactivated frontostriatal
functional connectivity.76,81,82 By contrast, decreased activity
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(hypometabolism) in similar prefrontal and striatal brain re-
gions has repeatedly been found in ADHD,73,83,84 along with
correspondingly reduced frontostriatal connectivity.85–87 To
our knowledge, the only study that directly compared neu-
ronal network abnormalities in ADHD and OCD found
increased activation in OCD and decreased functional con-
nectivity in ADHD.88
In light of the different clinical picture and the opposing
patterns of frontostriatal pathophysiology, it is important
to compare the associations between symptom severity and
frontostriatal activation in ADHD and OCD. A review of the
relevant literature shows that symptom severity and fron-
tostriatal activation are negatively associated in ADHD but
are positively associated in OCD. The first line of evidence
supporting this distinct pattern arises from research examining
the correlation between brain activity and disorder-specific
symptom severity. In ADHD, symptom severity (predomi-
nantly impulsiveness) appears to be inversely correlated with
brain activity in prefrontal89,90 and striatal85 regions. These
findings are supported by recent research demonstrating an in-
verse correlation between frontostriatal functional connectivity
and symptom severity in ADHD.84–86,91 By contrast, a positive
association between brain activity and symptom severity has
been repeatedly demonstrated in OCD.76,92–94 This interac-
tion was demonstrated in a recent study that compared OCD
and ADHD patients, reporting that the correlation of symp-
toms severity with frontostriatal brain activity was positive in
the OCD sample but negative in the ADHD sample.88
Neuropsychology of ADHD and OCD
The opposing clinical and neurobiological features of ADHD
and OCD support Hollander’s impulsive-compulsive contin-
uum model69 and, as such, appear to challenge the notion
of full-blown comorbidity between the two disorders. In-
terestingly, despite the opposing clinical and neurobiological
profile of the two disorders, individuals with ADHD and
OCD often present similar neuropsychological profiles. Both
disorders tend to underperform relative to nonpsychiatric
controls on tasks of executive functions, including working
memory, planning, and response inhibition.95–99 Our review
of the neuropsychological literature suggests, however, that
the similarity in neuropsychological performance between the
two disorders may be only apparent. Whereas neuropsycho-
logical findings in ADHD are highly consistent, neuropsycho-
logical findings in OCD are remarkably variable.95,100 For
example, whereas one recent meta-analysis suggested signifi-
cant heterogeneity across neuropsychological studies in adult
OCD,95 a similar meta-analysis in adult ADHD reported ho-
mogeneity across studies.101 In addition, meta-analyses exam-
ining neuropsychological function in ADHD suggested larger
effect sizes compared to those found in OCD.95,102,103 In fact,
it has recently been suggested that the moderate effect sizes
representing neuropsychological functioning in OCD may
not be clinically significant.95
The contrasting frontostriatal abnormalities and clini-
cal pictures of the two disorders suggest that the deficient per-
formance of people with ADHD and those with OCD on
neuropsychological tests may stem from different mecha-
nisms. A number of studies have revealed a negative ass-
ciation between neuropsychological test performance and
frontostriatal brain activity in OCD.92,104,105 By contrast,
frontostriatal brain activity was positively correlated with
neuropsychological test performance (predominantly execu-
tive functions) in ADHD.106–108 In sum, converging evidence
from imaging and neuropsychological studies suggests that
neuropsychological deficits and clinical manifestations are
associated with differing brain pathophysiology in ADHD
and OCD.
Pharmacological Treatment for ADHD and OCD
As noted above, impulsivity/disinhibition—the core symptoms
of ADHD—are associated with hypoperfusion of prefrontal
regions, whereas obsessiveness and compulsivity—the core
symptoms of OCD—are associated with increased activation.
For several decades, evidence-based expert guidelines have rec-
ommended stimulant medication such as methylphenidate as
the first-line treatment for ADHD.109,110 Modulating dopa-
mine reuptake, stimulant medication increases prefrontal acti-
vation and significantly improves both clinical symptomology
and neurocognitive functioning in ADHD.109,111,112 First-
line pharmacotherapy for OCD, by contrast, consists of
serotonin reuptake inhibitors (SRIs), which target seroto-
nergic pathways.113,114 These agents are thought to modu-
late hyperactivity along the frontostriatal network in OCD.
Indeed, clinical improvement following pharmacological
treatment or cognitive-behavioral therapy (CBT) is associ-
ated with a significant decrease in frontostriatal brain activ-
ity in OCD.75,115,116 Moreover, compulsive or repetitive
behavior in rats may be induced by administering the dopa-
mine agonist quinpirole117,118 and subsequently reduced by
administering clomipramine,119 an effective SRI medication
for OCD.120 Along the same lines, while stimulant medica-
tions alleviate symptoms in ADHD, they are thought to
exacerbate OCD symptoms and may even induce obsessive-
compulsive symptoms.121–124 Finally, whereas dopamine ag-
onists have proven efficacious in the treatment of ADHD,
dopamine blockers (i.e., neuroleptic/antipsychotic agents)
have been found to be useful for SRI augmentation among
OCD patients who only partially respond to SRIs.125
In sum, ADHD and OCD are two psychiatric syndromes
that appear to lie on opposite ends of an impulsive-compulsive
continuum (see Table 1). ADHD is characterized by reduced
frontostriatal activity (associated with symptom severity), im-
pulsive behavior, and positive response to stimulant therapy,
whereas OCD is characterized by increased frontostriatal activ-
ity (associated with symptom severity), inhibited behavior, and
harm- and risk-avoidance that responds to SRIs and dopamine
blockers and not to stimulants. These profound differences
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seem to challenge the possibility of a genuine comorbidity be-
tween the two conditions, at least on the theoretical level.
METHODS
We conducted a systematic literature search using PUBMED,
ISI Web of Knowledge, and PsycInfo electronic databases,
covering the period of 1980–2013.We also manually searched
the work of relevant authors and the reference lists of iden-
tified articles. Search terms included obsessive-compulsive
disorder,OCD, attention deficit/hyperactivity disorder, ADHD,
comorbid, comorbidity, concomitant, and prevalence. A
total of 206 abstracts was identified. We then excluded ar-
ticles that were not in English, where diagnosis was not es-
tablished using semistructured DSM-based measures, and
where co-occurrence data were not presented and were un-
obtainable. Following the secondary screening process, 48
studies met inclusion criteria and were included in the pres-
ent review, with publication dates ranging between 1990
and 2013. From these studies we examined 43 youth sam-
ples (<18 years of age) and 14 adult samples (≥18 years
of age).
RESULTS
Summary of Findings
Our review of the literature reveals that the reported rates
of ADHD-OCD co-occurrence are highly inconsistent, rang-
ing from 0% to 60%.4,8,9,22,33,36 A detailed account of
the samples reviewed for this manuscript is presented in
Tables 2 and 3.
The vast majority of reports examined pediatric samples
with a mean age ranging from 9 to 15 years. As shown in
Tables 2 and 3, pediatric studies demonstrate higher variabil-
ity in co-occurrence rates compared to adult and adolescent
samples. For example, Heyman and colleagues22 analyzed
data from the 1999 British Child Mental Health Survey,
which encompassed 10,488 children ages 5 to 15. The au-
thors reported that 40% of the 25 children diagnosed with
OCD had an additional comorbid psychiatric condition, but
none was diagnosed with ADHD. Similarly, Toro and col-
leagues2 reported that out of 72 children with OCD recruited
from hospital and private clinics, only 5.5% had a concomi-
tant diagnosis of ADHD. By contrast, Geller and colleagues15
examined 81 children from a specialty pediatric OCD clinic
and 106 children from a general pediatric psychopharmacol-
ogy clinic and reported that 59% of the children diagnosed
with OCD in the general psychopharmacology clinic and
44% of the children in the OCD specialized clinic had a con-
comitant diagnosis of ADHD. As we discuss below, the ex-
treme range of reported ADHD-OCD co-occurrence rates
between samples recruited from specialized clinics and the
general population (see Tables 2 and 3) may be partially due
to referral biases.
Whereas the above studies reported the occurrence of ADHD
in children diagnosedwithOCD, only a few studies documented
the occurrence of OCD in children and adolescents diagnosed
Table 1
Comparative Summary of Neurobiological, Neuropsychological, and Phenomenological Characteristics of
Attention-Deficit/Hyperactivity Disorder and Obsessive-Compulsive Disordera
Attention-deficit/hyperactivity disorder Obsessive-compulsive disorder
Functional neurobiology Hypoactivation Hyperactivation
anterior cingulated cortex, basal ganglia,
dorsolateral prefrontal cortex, frontostriatal
connectivity, orbitofrontal cortex, thalamus
anterior cingulated cortex, basal ganglia,
dorsolateral prefrontal cortex, frontostriatal
connectivity, orbitofrontal cortex, thalamus
Neuropsychology Underperformance Underperformance
Executive functions: planning, response
inhibition, working memory, set shifting,
attention, information-processing speed,
visuospatial working memory
Executive functions: planning, response
inhibition, working memory, set shifting,
information-processing speed,
visuospatial working memory
Phenomenology Impulsivity Inhibited behavior
Difficulty reflecting on consequences
of their actions
Excessively concerned with the
consequences of their actions
Risk taking Harm and risk avoidance
Lowered sensitivity to social cues Heightened alertness in social situations
Pharmacotherapy Dopamine agonists Serotonin agonists & dopamine blockers
Stimulants Selective serotonin inhibitors, with or
without neuroleptics
Source: Adapted from Abramovitch et al. (2012).126
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with ADHD. Interestingly, these studies report less variable
and relatively low co-occurrence rates of 3%–7.5%6,31,129
compared to studies examining ADHD in OCD samples
(0%–60%). A limited number of studies assessed ADHD-
OCD co-occurrence exclusively in adolescent samples. While
the variability in co-occurrence rates is somewhat similar to
that seen in pediatric and adult samples, ranging from 2%
to 36%, overall co-occurrence rates are generally lower than
in pediatric samples. In a study conducted in Sweden, Ivarsson
and colleagues23 examined 66 adolescents withOCD recruited
from general and specialized psychiatric clinics and concluded
that 10.6% of them exhibited concomitant ADHD. As in the
case of pediatric OCD, we found only two studies reporting
the occurrence of OCD in ADHD adolescent samples. Both
studies were conducted in Israel and found concomitant OCD
in 2.6% and 8% of participants with ADHD, respectively.5,128
The adult literature reveals a similar number of studies
reporting the occurrence of ADHD in OCD samples and
OCD in ADHD samples. While somewhat lower compared
to those found in the pediatric literature, rates of the occur-
rence of ADHD in OCD samples are inconsistent, ranging
from 0% to 23%. For example, in one of the largest samples
included in our review, Jaisoorya and colleagues24 recruited
192 adults with OCD from specialized outpatient and in-
patient clinics. The authors reported that 2% of their sample
had a concomitant diagnosis of ADHD.
In contrast to the large number of co-occurrence reports
in clinical settings, only one study reported prevalence of
OCD in adult individuals with ADHD in a nationally repre-
sentative sample. Kessler and colleagues46 used data from
the US National Comorbidity Survey to examine comorbidi-
ties within a sample of 154 adults with ADHD. The authors
reported that 2.7% of their ADHD sample had OCD, a find-
ing that remarkably resembles the prevalence rate of OCD
observed in the general population (2.3%).49 Interestingly,
Ruscio and colleagues49 analyzed data collected from the
same US National Comorbidity Survey and found that 19%
of the OCD group (n = 73) had ADHD. Similar variability
was found in studies reporting the occurrence of OCD in
ADHD samples (1%–13%).
In sum, our review of the literature reveals notable vari-
ability in reported ADHD-OCD co-occurrence rates, as well
as lower co-occurrence rates and less variability in adult as
compared to youth samples. In addition, higher co-occurrence
rates are reported for ADHD in OCD samples than for
OCD in ADHD samples. Below, we suggest methodological
factors that may account for this divergence in reported co-
occurrence rates.
Methodological Issues
SAMPLE CHARACTERISTICS Most of the studies examining ADHD-
OCD co-occurrence examined clinical samples in specialty
clinics, whereas only few examined non-referred or general
population samples. The latter are the only reliable source from
which inferences regarding prevalence in the epidemiologicalT
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sense can be drawn. Importantly, the range of ADHD-OCD
co-occurrence rates in the three studies of large re-
presentative samples22,46,128 was between 0% and 10%,
whereas most of the studies using samples from specialized
clinics found co-occurrence rates of 20% to 59%. The dis-
crepancy between the co-occurrence rates found in referred
samples versus the general population is a well-known phe-
nomenon130,131 that may be accounted for by two types
of selection biases that are often underrecognized.132 The
Berksonian bias133 expresses how every additional diagno-
sis increases the probability that a person will be referred
to mental health services, whereas the related clinical selec-
tion bias134 refers to the fact that individuals with multiple
diagnoses are usually more functionally impaired and thus
are more likely to pursue treatment. Ultimately, these biases
lead to a substantial overrepresentation of patients with
comorbidities in specialized clinics relative to the general pop-
ulation. For example, McConaughy and Achenbach131 ana-
lyzed studies encompassing 2705 juvenile patients across
four groups of disorders. They found that comorbidity rates
in samples drawn from clinical settings were up to six times
higher than those seen in non-referred or general population
samples. Notably, several studies we reviewed recruited par-
ticipants from different referral sources such as outpatient,
inpatient, and private clinics,24,29,45 thereby potentially in-
creasing the variability of reported co-occurrence rates.
EXCLUSION CRITERIA As portrayed in Tables 2 and 3, the stud-
ies we reviewed also differed considerably in terms of exclu-
sion criteria. Some studies of adult, pediatric, or adolescent
samples did not employ any exclusion criteria,5,12,15,26,27,44,48,49,128
whereas most studies excluded patients with mental retar-
dation, psychosis, autism, or autistic spectrum disorders.
Some studies also excluded major depressive and other Axis
I disorders.1,18,24,32,50
Arguably, epidemiological examination of the preva-
lence rates of, and associations between, co-occurring condi-
tions would benefit in terms of generalizability and ecological
validity if no exclusion criteria were used. This is particularly
important in the case of ADHD and OCD, both of which are
characterized by a high prevalence of comorbidity with anxi-
ety, tic, and depressive disorders. In this case, the exclusion of
depressive or anxiety disorders may bias the reported preva-
lence rates and limit generalizability. One way to resolve this
problemwouldbe toprovide adetailed account of the theoret-
ical considerations underlying the selection of exclusion
criteria determined for each study. Unfortunately, in the vast
majority of the articles we reviewed, no explanations were
offered for the choice of exclusion criteria.
In the case of ADHD-OCD co-occurrence, both excluding
and failing to exclude particular diagnostic groups may have
important consequences for the findings and their interpre-
tation. For example, autistic spectrum disorders are associ-
ated with both impulsive and obsessive-compulsive symptoms
and are highly comorbid with both ADHD and OCD.135,136T
ab
le
3
C
on
tin
ue
d
St
ud
y
n
M
ea
n
ag
e
A
ge
ra
ng
e
Pe
rc
en
ta
ge
m
al
e
Sa
m
pl
e
Ex
cl
us
io
n
cr
ite
ri
a
Pe
rc
en
ta
ge
A
D
H
D
w
ith
in
O
C
D
Pe
rc
en
ta
ge
O
C
D
w
ith
in
A
D
H
D
K
es
sl
er
et
al
.
(2
00
6)
4
6
15
4
N
/A
18
–4
4
N
/A
N
at
io
na
ls
ur
ve
y
N
/A
2.
7
W
ile
ns
et
al
.
(2
00
9)
5
2
10
7
37
19
–6
0
59
Ps
yc
ho
ph
ar
m
ac
ol
og
y
pr
og
ra
m
D
ea
fn
es
s,
bl
in
dn
es
s,
ps
yc
ho
si
s,
IQ
<
80
12
N
/A
,n
ot
av
ai
la
bl
e.
A. Abramovitch et al.
254 www.harvardreviewofpsychiatry.org Volume 23 • Number 4 • July/August 2015
Therefore, including autistic spectrum disorders may inflate
co-occurrence rates of ADHD and OCD.
Most importantly, as observed by Sheppard and col-
leagues,51 few reports have assessed the co-occurrence of ADHD
and OCD while excluding tic disorders (i.e., Tourette’s syn-
drome and chronic tic disorders). Comorbidity between tic dis-
orders and OCD and between tic disorders and ADHD has
been consistently found across numerous tic disorder studies,
with co-occurrence rates ranging from 25% to 50%.137–140
In addition, very high rates of concomitant ADHD and OCD
are regularly identified in tic disorder samples. For example,
Lebowitz and colleagues138 examined a sample of 158 youth
with chronic tic disorders and found that 24.1% had ADHD
and OCD. Grados and Mathews137 found that 34% of a
sample of 596 patients with tic disorders had OCD and
ADHD. Elevated prevalence rates of ADHD-OCDcomorbid-
ity were also reported in first-degree relatives of patients with
tic disorders.139
In our review, only four of the pediatric and adolescent
samples (12%) excluded tic disorders. Given the high comor-
bidity of tic disorders with both ADHD and OCD,141,142
along with the elevated co-occurrence of ADHD and OCD
in tic disorders,138 inclusion of tic disorders may lead to
inflated rates of reported ADHD-OCD comorbidity. A few
studies did not exclude tic disorders but did control for their
presence when reporting results. For example, Geller and col-
leagues19 reported the co-occurrence of ADHD and OCD in
unaffected relatives beyond that expected by chance, and
found that co-occurrence was significant over and above the
presence of tic disorders. The authors noted, however, that
given the evidence suggesting that tic disorder, ADHD, and
OCD often co-occur in families, it is plausible that some
shared susceptibility genes account for some features of the
three disorders. To our knowledge this study is the only one
that specifically examined ADHD-OCD comorbidity while
controlling for tic disorders, and more familial and epidemio-
logical research is needed to replicate these findings and to fur-
ther explore themediating role of tic disorders in ADHD-OCD
comorbidity. It is important to note that the majority of the
studies reviewed in this article did not set out to examine
ADHD-OCD co-occurrence in particular but typically aimed
at examining a variety of general clinical variables or the prev-
alence of comorbid conditions in either ADHD or OCD.
ADULT VS. PEDIATRIC POPULATIONS Our review of the literature
reveals notable differences in ADHD-OCD co-occurrence
rates reported in adult versus youth samples. As presented
in Tables 2 and 3, considerably higher co-occurrence rates
are found in youth samples (unweighted mean = 19%) relative
to adult samples (unweighted mean = 9%).* In an attempt
to account for this difference, it may be useful to consider
neurodevelopmental aspects of pediatric OCD (for a review
see Abramovitch et al. [2012]).143 Specifically, pediatric OCD
may be neurobiologically distinct from OCD in adolescent
and adult populations. As mentioned above, ample evidence
suggests the presence of frontostriatal hypermetabolism in
adults with OCD, but the same does not seem to hold for
young children with OCD.
In a large-scale fMRI study, Fitzgerald and colleagues144
compared the resting-state frontostriatal connectivity of 60 in-
dividuals with OCD (age range, 8–40 years) and 61 matched
healthy controls. The authors observed significantly increased
connectivity in the OCD group relative to controls. In the
youngest age group (mean age = 10.7), however, they found
reduced functional connectivity that was correlated with
OCD symptom severity. These findings may be attributed to
abnormal maturational processes in pediatric OCD, which
are hypothesized to encompass maturational reorganization,
neuronal pruning, and myelination.145
Thus, in contrast to adolescent and adult OCD, pediat-
ric (preadolescence) OCD may be associated with decreased
frontostriatal activity, a recognized endophenotypic marker
for ADHD that has been consistently identified across the
lifespan. As reduced frontostriatal activation is associated with
impulsive behavior,146 preadolescent OCD patients may dis-
play behaviors and symptoms that may potentially lead tomis-
identification of OCD as ADHD, consequently inflating the
rate of reported comorbidity of the two disorders. This possi-
bility is discussed in more detail below. At present, however,
scant research has investigated the maturation and pruning
processes in pediatric OCD. In view of the arguments sup-
porting a distinct familial type of ADHD-OCD,19 and given
the different developmental trajectories characterizing the
two disorders, longitudinal investigation of the neurobiologi-
cal changes and associated symptoms is much needed.
GENDER RATIOS The samples we reviewed were highly variable
in terms of male:female ratios. Across samples, the percent-
ages of males ranged between 36% and 100%, with a mean
of 62% and a standard deviation of 15.5%. Considering
the higher prevalence of ADHD in males relative to females,
this level of variability may further confound research find-
ings. Among adults and children with ADHD, the ratio of
males to females is at least 2:1,147 with some estimates as high
as 9:1, depending on ADHD subtype, age range, and sample
characteristics.148,149 Whereas the average of 62% males in
ADHD samples may be methodologically sound (as it reflects
the conservative reports of 2:1 male:female ratio in ADHD),
a higher proportion of males than females in OCD samples
may artificially inflate the probability of finding cases of
ADHD. For example, Farrell and colleagues10 reported that
19% of their sample of children and adolescents diagnosed
with OCD met criteria for ADHD. The percentage of males
in the OCD-only group was 23%, however, versus 77% in
the OCD-comorbidity group, which included ADHD, perva-
sive developmental disorder, and depression. While matching
* The nature of the reviewed samples does not allow for statistical analyses
assessing differences between samples. Thus, when using terms such as higher or
lower, we do not imply statistical significance.
Comorbidity of ADHD and OCD
Harvard Review of Psychiatry www.harvardreviewofpsychiatry.org 255
groups in naturalistic studies is impossible, few of the studies
we reviewed have acknowledged this potential bias.
ETIOLOGICAL ACCOUNTS OF
ADHD-OCD COMORBIDITY
Concomitant ADHD-OCD as a Familial Subtype
Psychiatric comorbidity research is susceptible to several arti-
facts, including chance, sampling bias, unique samples that
limit generalizability, and definitional overlap.150 For this rea-
son, an etiological account is essential for assessing the legiti-
macy and validity of any psychiatric comorbidity. To our
knowledge, the only etiological account of ADHD-OCD co-
morbidity was put forth by Geller and colleagues19,20 and is
limited to youth.
In the first study of its kind, Geller and colleagues14 exam-
ined 121 school-age children and adolescents (67 with ADHD
and 54 with comorbid ADHD-OCD). The authors compared
the groups on several factors, including DSM-IV ADHD
symptoms and clusters, frequency of ADHD subtypes, and
several ADHD-related functional indices. The authors ob-
served no differences between the groups on these variables
and suggested that ADHD symptoms in OCD represent a
genuine comorbidity between ADHD and OCD. In a later
study,19 the same group examined a sample of 256 children
with ADHD alone, 12 with OCD and ADHD, 235 controls,
and 1540 first-degree relatives. They concluded that “(1) rela-
tives of children with ADHD with and without OCD had
similar and higher rates of ADHD than did relatives of non-
ADHD comparison children, (2) the risk for OCD was ele-
vated only among relatives of ADHD + OCD probands,
(3) a strong and significant finding of co-segregation between
ADHDandOCD emerged.”The authors also postulated that
“in children, ADHD that is comorbid with OCD represents a
distinct familial subtype.”19 In other words, according to
Geller and colleagues, comorbid ADHD-OCD is a distinct
condition in which the two disorders are genetically transmit-
ted together. Notably, and in contrast to the co-occurrence
suggested by Geller and colleagues19—the simultaneous pre-
sentation of two conditions that are not necessarily corre-
lated in the general population—Lilienfeld and colleagues130
have argued that this type of comorbidity constitutes covaria-
tion, in which two conditions co-occur more often than ex-
pected by chance.
In sum, to date, only one etiological account has been of-
fered for genuine ADHD-OCD comorbidity in children.19,20
This account postulates a unique and heritable condition
consisting of a full-blown comorbidity of ADHD and OCD.
To date, no familial studies on adults with ADHD-OCD co-
morbidity have been published.
The Executive Overload Model of OCD
A potential confounding factor that may contribute to both
inflation and variability of reported co-occurrence of ADHD
and OCD was recently suggested by Abramovitch and
colleagues.126 As noted above, despite the phenomenologi-
cal and neurobiological differences between ADHD and
OCD, both disorders may be associated with some degree
of reduced abilities in attention and executive function.
Abramovitch and colleagues conducted a direct comparison
of neuropsychological functioning of adults with ADHD
and adults with OCD. As expected, the authors found that
compared to nonpsychiatric controls, both patient groups
underperformed on several neuropsychological tasks. At the
same time, this study noted significant differences between
the disorders in disorder-specific symptoms (e.g., ADHD sub-
jects had higher impulsivity ratings compared to controls,
whereas the OCD group did not differ from controls). Perhaps
more importantly, neuropsychological underperformance was
positively correlated with obsessive-compulsive symptoms in
the OCD group but negatively correlated with obsessive-
compulsive symptoms in the ADHD group.126 The authors
proposed an Executive Overload Model, which focuses on
the cognitive “cost” of obsessions in OCD. Specifically, they
postulated that the overflow of obsessive thoughts in OCD
may overload the executive system, subsequently resulting
in neuropsychological deficits. Based on this rationale, the
authors suggested that neuropsychological impairments in
OCD should be conceived as an epiphenomenon in that they
are associated with state-dependent symptom severity.
The Executive Overload Model may have important im-
plications for the observed ADHD-OCD co-occurrence. It
suggests that ADHD symptoms in OCD might actually be
ADHD-like symptoms; that is, they may be behavioral man-
ifestations of OCD-related neurocognitive impairment. Par-
tial support for this possibility was provided in a another
report by the same group,53 where the authors reasoned that
if ADHD-like symptoms inOCD are actually a result of OCD-
related symptoms, then childhood and adult ADHD symp-
toms would not be correlated within the OCD group. In
support of this hypothesis, the authors found strong signifi-
cant correlations between childhood and adult ADHD symp-
toms only in the ADHD and control groups.53
In sum, the Executive Overload Model126 suggests that
the comorbidity between the two disorders in some cases
may be only apparent and may actually reflect the presence
of ADHD-like symptoms in OCD. Such ADHD-like symp-
toms may be especially pronounced in pediatric populations
due to the hypothesized maturational abnormality in young
children with OCD. Furthermore, the underlying OCD-related
attentional symptoms may be incorrectly interpreted as indica-
tions of ADHD, especially in pediatric populations, in which
diagnosis relies heavily on informants. Such misdiagnosis
may be especially problematic if it leads to stimulant therapy,
which may significantly exacerbate OCD symptoms.121,122
DSM Diagnostic Criteria
Criterion E for the diagnosis of ADHD in the DSM-IV requires
that “the symptoms do not occur exclusively during the course
of a Pervasive Developmental Disorder, Schizophrenia, or
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other Psychotic Disorder and are not better accounted for
by another mental disorder (e.g., Mood Disorder, Anxiety
Disorder, Dissociative Disorder or a Personality Disorder).”58
As suggested by Abramovitch and colleagues,126 it is pos-
sible that the overflow of obsessive thoughts in individ-
uals with OCD overloads the executive system, leading to
behavioral expressions similar to several DSM-IV ADHD
criteria (e.g., difficulties in concentration, feeling of restless-
ness, avoidance of tasks that require cognitive effort, distrac-
tion by extraneous stimuli). It has already been noted that
DSM-IVADHD criteria pertaining to restlessness, increased
speech, concentration difficulties, hyperactivity, and so on
are also symptoms of other anxiety, affective, and personal-
ity disorders.151 Thus, behavioral and cognitive expression
of OCD-related inattention symptoms may be misidentified
as ADHD symptoms, potentially leading to a false DSM-IV
diagnosis of ADHD.†
Moreover, the hallmark symptoms of ADHD (i.e., impul-
sivity) and OCD (i.e., compulsivity) are phenomenologically
opposite. Compulsions are typically rituals that are carefully
planned and repetitively performed according to rigid rules.
In addition, clinical experience indicates that OCD patients
are able to inhibit or postpone compulsive rituals (e.g., at
work). Behavioral impulsivity, by contrast, is characterized
by actions that are performed without forethought and with
little ability to inhibit or postpone them. As noted above, sev-
eral studies observed equal or decreased behavioral impul-
sivity in OCD patients relative to healthy controls. Indeed,
as noted by Angold and colleagues,153 a paucity of research
has investigated the differential characteristics of symptoms
between comorbid disorders in general; that is, research ex-
amining disorder-specific versus shared symptoms between
comorbid conditions is limited. For example, while patients
with either ADHD or OCD appear to present symptoms of
inattention, some aspects of that inattention that may be
disorder-specific, and their identificationwould increase diag-
nostic accuracy. Future research into the differential charac-
teristics of shared ADHD and OCD symptoms may aid in
untangling this complex issue.
SUMMARY
OCD and ADHD are very different disorders in terms of
pathophysiology, phenomenology, and treatment strategies
(see Table 1). Numerous studies, however, have reported sig-
nificant rates of ADHD-OCD co-occurrence. Increased co-
occurrence rates were found in children and adolescents as
compared to adults. In this review, we documented extreme
variability across studies, with co-occurrence rates ranging
from 0% to 60%. An attempt to provide an etiological ac-
count for ADHD-OCD comorbidity, primarily genetic in na-
ture, was made only with regard to children.19 Few studies
directly examined co-occurrence between ADHD and OCD
in adults. Much more research is required to validate
ADHD-OCD co-occurrence, let alone comorbidity, in this
population. Specifically, more research is required to examine
false comorbidity versus covariation of ADHD and OCD;
such clarification would have important clinical implications.
Several methodological concerns have been identified in
our review. First, we found gender proportions to vary signif-
icantly between samples, which may result in a bias in preva-
lence reports, as ADHD is more frequent in males. Second,
most studies recruited patients from specialized clinics rather
than from the community or representative samples. Given
that few studies examined representative samples and that
significantly higher rates of ADHD-OCD co-occurrence have
been reported in samples recruited from specialized clinics,
our understanding of the prevalence of co-occurring ADHD
and OCD may be largely based on biased results. Third, we
identified high variability in terms of exclusion criteria be-
tween samples. Most critically, the great majority of the stud-
ies did not exclude or control for tic disorders, a mediator and
potential confound for ADHD-OCD co-occurrence.
As noted by Pennington and colleagues,150 a theoretical
and etiological account is essential to validate a true comor-
bidity between disorders. Only one etiological account for
ADHD-OCD comorbidity, which postulates a distinct herita-
ble ADHD +OCD condition, is currently available.19 Finally,
a potential confounding factor that received little attention is
addressed by the Executive Overload Model offered by
Abramovitch and colleagues.126 That model suggests that
deficits in attention and executive function may be state de-
pendent in OCD, resulting in a subsequent phenotypical ex-
pression that may resemble ADHD symptoms.
We suggest that future studies on ADHD-OCD comorbid-
ity should strive to mitigate the biases and potential con-
founds elaborated above. Future studies should aim to
address the potential bias associated with gender proportions
andmight be also advised to consider age stratification. Addi-
tionally, examination of ADHD-OCD in community samples
is necessary to balance the majority of reports, which re-
cruited participants via specialty clinics. Recruitmentmethod-
ology ought to be more carefully considered in light of the
known effects of the Berksonian and clinical-selection biases.
If aggregation of various recruitment methods is necessary,
future research ought to differentiate between cohorts re-
cruited from different sources. Researchers are advised to
carefully consider exclusion criteria when examining ADHD-
OCD comorbidity, and should provide justifications for
these criteria. Specifically, the control or exclusion of tic dis-
orders ought to be carefully assessed due to their possible
mediating effect on the estimation of ADHD-OCD co-
occurrence. Moreover, according to the Executive Overload
Model, ADHD-like symptoms may be present in OCD. Both
† We have omitted discussion of DSM-5 in this review for two primary reasons.
First, the review pertains to studies that employed DSM-IV or DSM-III. Second,
DSM-V changes to ADHD criteria pertain to the hyperactivity/impulsivity symp-
tom cluster and do not apply to the inattention cluster. We should also note that
according to a recent analysis,152 these changes may potentially reduce diagnostic
specificity and inflate diagnosis rates of ADHD, further complicating the problem
presented here.
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clinicians and researchers ought to pay careful attention to
this issue, especially in cases where comorbid tic disorders
are identified.
The paucity of knowledge regarding ADHD-OCD comor-
bidity in adults needs to be addressed through further re-
search. Our review underlines the need for more studies in
this population, especially investigations into community
samples. Additionally, prospective longitudinal studies are re-
quired that would examine the developmental trajectory of
ADHD-OCD comorbidity. Such studies would be invaluable
in elucidating factors differentiating ADHD-like symptoms
in OCD from genuine comorbidity between the two disorders.
Finally, the ultimate aim of research on psychiatric comorbid-
ity is to further our understanding of complex conditions so
as to advance treatment and prognosis.154 Along these lines,
the first aim of the present investigation was to establish if
ADHD and OCD are genuinely comorbid. The conclusion
would have critical implications for treatment, especially in
view of the well-known efficacy of treatment options for
the two disorders (considered separately)—namely, stimulant
medication (and possibly CBT) for ADHD,155,156 and CBT
and SRIs for OCD.157 Several authors have suggested that in-
dividuals with comorbid ADHD-OCD are more functionally
impaired. And if such comorbidity proves to be as common
as some studies suggest, it is imperative to determine effective
treatments for this complex condition.
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